19:40 , Oct 3, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Colorectal cancer; pancreatic cancer Patient sample, cell culture and mouse studies suggest antibiotics could help treat Gemzar gemcitabine-resistant colorectal and pancreatic cancers. In 113 tumor samples from pancreatic ductal adenocarcinoma (PDAC) patients, bacterial DNA --...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Clinical News

Lynparza Olaparib: Phase I started

Cancer Research UK began the open-label, dose-escalation, U.K. Phase I PIONEER trial to evaluate once- or twice-daily oral Lynparza in combination with Xeloda capecitabine and radiotherapy in up to 36 patients whose disease has...
08:00 , Feb 29, 2016 |  BC Week In Review  |  Clinical News

AMG 319: Phase II started

Cancer Research UK (London, U.K.) began a double-blind, placebo-controlled, U.K. Phase II trial to evaluate 400 mg oral AMG 319 once daily for 21-30 days prior to resection in up to 54 patients. Cancer Research...
07:00 , Jul 16, 2015 |  BC Innovations  |  Finance

Foundation in disrepair

The multiple sclerosis community will lose one of its advocates for investing in research on reversing the disease when the Myelin Repair Foundation (MRF) closes its doors next month due to lack of funding that...